Pharmaceutical Industry

Drug Development Drug Pricing Drug Manufacturing Market Trends Generic Drugs Manufacturing Drug Safety Clinical Trials Market Competition Research and Development

Isomorphic Labs Reportedly Seeks $40–$50 Billion Valuation in Early Funding Talks

The reported discussions signal strong investor demand for AI drug discovery despite the company having no clinical data yet.

Multiple Law Firms Press Securities Suits Against Anavex Over Blarcamesine Setback and CEO Firing

Court Rules Liquidia’s Yutrepia Infringes United Therapeutics Patent

Novo Nordisk Teams With Anthropic to Test Claude for Drug Discovery

SK Biopharmaceuticals Licenses Biohaven’s Opakalim in Deal Worth Up to $795 Million

Hanmi Licenses HM17321 to Genentech in $190 Million Upfront Deal Valued at $2.3 Billion

Sandoz Agrees to $478.5 Million U.S. Settlement Over Generic Drug Pricing

Trump Announces Phased Tariffs on Imported Generic Medicines

Red Tech Brings SHINVA and SMA Pharmaceutical Equipment to Brazil

Novo Nordisk Sues Eli Lilly Over U.S. Weight‑Loss Ads

Novo Nordisk Sues Eli Lilly Over National Ads for Obesity Drugs

U.S. Trade Pressure Puts Swiss Pharma at Risk of Investigation

Moderna Signals Interest in Buying Biontech's German Plants

Hackers Claim More Than 1TB Stolen From Novo Nordisk

Eli Lilly and Boehringer Cut Planned Germany Investments, Signalling Risk to Pharma Hub

Boehringer Ingelheim and Eli Lilly Cut Major Germany Investments

Sanofi Launches 'Concierge for Field' AI Sales Agent Built on Snowflake

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Mangione Supporter Linked to CVS Health Executive After Praising CEO's Killing

Kissei Discloses 20 Deaths in Japan Among Tabneous Users